ibe_banner

68858-20-8 Fmoc-L-Val-OH

68858-20-8 Fmoc-L-Val-OH

Nkọwa dị mkpirikpi:

Ọdịdị Na-acha ọcha na-acha ọcha ntụ ntụ
MF C20H21NO4
MW 339.39
Ịdị ọcha 98+


Nkọwa ngwaahịa

Ọnọdụ njem
Nwere ike ịdị na okpomọkụ nkịtị

Kwado usoro mbupu
Site ikuku Site n'ala Site n'oké osimiri

Ọnọdụ nchekwa:
Debe n'ebe gbara ọchịchịrị, ikuku na-adịghị mma, okpomọkụ ụlọ

Ndụ nchekwa
Ihe dị ka afọ 2

Ọnụ ego kacha nta:
1kg (mkparịta ụka)

Asambodo:COA, ebe mgbaze, SpecificRotation [α]D20                      

Anyị ga-eziga data ọ bụla ịchọrọ.Ị nwere ike ịhụ data n'ihu dị ka ntụaka.

Maka ngwaahịa ahaziri ahazi, anyị na-eziga data kachasị ọhụrụ mgbe ha pụtachara.

D-Lys(tfa) -NCA (2)

Ntụpọ

FMOC-L-Valine

N-FMOC-VAL-OH

N-FMOC-L-VAL

N-FMOC-L-VALINE N-(9-FLUORENYLMETHOXYCARBONYL)-L-VALINE

N-9-FLUORENYLMETHILOXYCARBONYL-L-VALINE

N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-L-VALINE

N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-L-VALINE N-ALPHA-FMOC-L-VALINE

Nkwakọ ngwaahịa n'ime

A na-ejikarị ha eme ihe maka ịkwakọba ntụ ntụ.Ọ dabere na ihe ndị ahịa chọrọ.Ya mere, gwa anyị ihe ị na-achọ tupu ịkwakọ ngwaahịa ma ọ bụrụ na ị nwere arịrịọ pụrụ iche.

Nkwakọ ngwaahịa dị n'ime 2
Nkwakọ ngwaahịa dị n'ime 1
Nkwakọ ngwaahịa dị n'ime 3

mpụta mbukota

1kg ruo 25kg Mbukota mpụta siri ike.Ọ na-esikwa ike ịkpụ na imebi.Ọ nwere ike ichekwa ngwaahịa gị nke ọma.

Mkpokọta mpụta 3
Mkpokọta mpụta 2
Nkwakọ ngwaahịa dị n'èzí 1

Ngwa

68858-20-8 Fmoc-L-Val-OH bụ otu n'ime etiti Abaloparatide.

Nke mbụ, Abaloparatide na-arụ ọrụ iji chịkwaa metabolism ma kwalite ọkpụkpụ ọkpụkpụ site na ịhọrọ ọwa akara nke PTH1 ụdị 1 receptor (PTH1R).Ọ na-abawanye njupụta ọkpụkpụ nke ukwuu ma na-ebelata ihe ize ndụ nke mgbaji.Nnyocha egosiwo na n'ime ndị ikom nwere osteoporosis, ọgwụgwọ na Abaloparatide nke ukwuu ma na-eme ngwa ngwa BMD (njupụta ịnweta ọkpụkpụ) nke ọkpụkpụ azụ, olu femoral, na mkpokọta hip ma e jiri ya tụnyere placebo.

Nke abuo, Abaloparatide akwadoro maka ire ahịa site na US Food and Drug Administration (FDA) maka ọgwụgwọ osteoporosis na ụmụ nwanyị postmenopausal bụ ndị nwere ihe ize ndụ nke mgbaji ma ọ bụ ndị na-azaghachighị ndị ọrụ ọgwụgwọ ndị ọzọ.Tụkwasị na nke ahụ, a na-egosikwa ọgwụ ahụ maka ndị ikom toro eto bụ ndị a na-egosighị ọgwụgwọ ngbanwe testosterone iji belata ihe ize ndụ nke onye ọrịa nke ọkpụkpụ vertebral na iji mee ka ọkpụkpụ dị ike na hip na ọkpụkpụ na-abụghị nke hip.

Mgbe ị na-eji Abaloparatide, usoro a na-atụ aro bụ 80mcg a na-enye subcutaneously otu ugboro kwa ụbọchị.Ọ bụrụ na nri onye ọrịa ezughị oke, calcium na vitamin D kwesịrị ịgbakwunye ya. Tupu ịnye ya, jide n'aka na sirinji ọgwụ na agịga dị ọcha na adịghị ike.

N'ozuzu, egosipụtara na Abaloparatide dị irè na ọgwụgwọ osteoporosis ma jiri ya mee ihe n'ọtụtụ ebe na ụlọ ọgwụ.

ngwaahịa ndị metụtara ya

L-Val-OH D-Val-OH N-Me-D-Val-OH Pht-Val-OH
AC-Val-OH Boc-L-Val-OH Boc-D-Val-OH Boc-N-Me-Val-OH
Fmoc-D-Val-OH Cbz-L-Val-OH Cbz-D-Val-OH Cbz-Val-Val-OH

Gịnị mere Họrọ Anyị

1. Banyere MOQ: Anyị nwere ike ịhazigharị ya dịka ihe ị chọrọ.
2. Banyere ihe atụ: Ihe nlele ahụ chọrọ ego nlele, nke nwere ike ibu ibu iji nakọta ma ọ bụ ị nwere ike ịkwụ anyị ụgwọ tupu oge eruo.
3. Ụlọ ihe omumu ihe, enwere ike ịhazi ya dị ka ọnụ ọgụgụ nke ụdị.
4. Anyị na-enye ọrụ kacha mma.Otu ndị ahịa nwere ahụmahụ na-arụ ọrụ maka gị.
5. Banyere mgbanwe: Biko email ma ọ bụ kpaara m nkata na gị mma.


  • Nke gara aga:
  • Osote:

  • Dee ozi gị ebe a ziga anyị ya